Cargando…
Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancer
BACKGROUND: XRCC4 is a NHEJ factor identified recently that plays a vital role in repairing DNA double-stranded breaks. Studies have reported the associations between abnormal expression of XRCC4 and tumor susceptibility and radiosensitivity, but the potential biological mechanisms by which XRCC4 ex...
Autores principales: | Yu, Yang, Sun, Yanyan, Li, Zhaoxian, Li, Jiang, Tian, Dazhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921312/ https://www.ncbi.nlm.nih.gov/pubmed/36765282 http://dx.doi.org/10.1186/s12859-023-05165-8 |
Ejemplares similares
-
Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker
por: Qiu, Yingqi, et al.
Publicado: (2022) -
Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker
por: Yang, Yaqi, et al.
Publicado: (2022) -
Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker
por: Cheng, Xin, et al.
Publicado: (2021) -
Systematic pan‐cancer analysis identifies RBM39 as an immunological and prognostic biomarker
por: Zhang, Rui, et al.
Publicado: (2022) -
Systematic pan-cancer analysis identifies cGAS as an immunological and prognostic biomarker
por: Chen, Peng, et al.
Publicado: (2023)